Ascent Group’s Boston Scientific BSX Stock Holding History

Ascent Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.17M	Sell	34,601 -1,168	-3%	-$93.4K	0.08%	237
2025 Q4	$3.41M	Sell	35,769 -3,802	-10%	-$373K	0.12%	174
2025 Q3	$3.86M	Sell	39,571 -5,577	-12%	-$578K	0.14%	150
2025 Q2	$4.85M	Sell	45,148 -4,794	-10%	-$485K	0.19%	113
2025 Q1	$5.04M	Buy	49,942 +34,645	+226%	+$3.49M	0.22%	101
2024 Q4	$1.37M	Buy	15,297 +7,009	+85%	+$617K	0.1%	237
2024 Q3	$695K	Buy	8,288 +808	+11%	+$63.7K	0.05%	331
2024 Q2	$576K	Buy	7,480 +790	+12%	+$57.8K	0.05%	336
2024 Q1	$458K	Sell	6,690 -72	-1%	-$4.63K	0.04%	373
2023 Q4	$439K	Buy	6,762 +303	+5%	+$16.2K	0.04%	367
2023 Q3	$332K	Buy	6,459 +541	+9%	+$28.4K	0.04%	371
2023 Q2	$299K	Sell	5,918 -310	-5%	-$16.2K	0.03%	375
2023 Q1	$312K	Buy	+6,228	New	+$294K	0.03%	396

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ascent Group's BSX Position: Q1 2026 in Review

Ascent Group reduced its Boston Scientific (BSX) stake by 3.3% in Q1 2026, selling an estimated $93.4K and leaving 34,601 shares worth $2.17M. The position accounts for 0.08% of the portfolio, ranked #237.

Ascent Group first reported a position in BSX in Q1 2023 and has held it in 13 quarters since. The position peaked at $5.04M in Q1 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Ascent Group held 34,601 shares of Boston Scientific worth $2.17M as of Q1 2026.
Ascent Group sold 1,168 Boston Scientific shares in Q1 2026, an estimated $93.4K.
Boston Scientific made up 0.08% of Ascent Group's portfolio in Q1 2026, its #237 holding.
Ascent Group first reported a position in Boston Scientific in Q1 2023 and has held it in 13 quarters since.
Ascent Group's Boston Scientific position peaked at $5.04M in Q1 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Ascent Group's 13F filing for Q1 2026, filed 15 May 2026.